Since its founding in 2005, Actavis Inc., the US subsidiary of Actavis Group, has consistently ranked among the top 10 generic pharmaceutical manufacturers in the United States, while earning a reputation for superior service and value.

With more than 150 prescription and non-prescription products available in the United States, Actavis is committed to helping provide affordable health care by offering high value, lower cost medical solutions. More than 80 additional products are pending FDA approval for release.

Actavis products are used for a wide range of therapeutic indications and available in various dosages and forms, including tablets, capsules, liquids and creams. To view our complete line of products, please visit our Product List.

Along with its extensive portfolio of generic prescription medications, Actavis offers several non-prescription products under the Actavis label and supplies them to some of the nation’s leading retailers for store-brand sales.

In addition to its Morristown, NJ, headquarters, the company operates manufacturing and related facilities in Elizabeth, NJ, and Lincolnton, NC; and research and development facilities in Sunrise, FL, and Owings Mills, MD.

Company Highlights

Actavis Inc. formed in 2005 with the acquisitions of Amide Pharmaceutical Inc., and the human generics division of Alpharma Inc, making it one of the top 10 generic manufacturers in the United States. Parent company Actavis Group is one of the world’s five-largest generic pharmaceutical companies.

The following year, Actavis entered the US specialty generics market with the acquisition of South Florida-based Abrika Pharmaceuticals, becoming one of the nation’s leading manufacturers of complex extended-release medications.

The company has invested significantly in its facilities, doubling the size of its Florida laboratory and expanding capacity of its sites in Owings Mills, MD, Elizabeth, NJ, and Lincolnton, NC.